Genocea promotes Chip Clark to president and CEO
This article was originally published in Scrip
Executive Summary
Genocea Biosciences, a vaccine discovery and development company developing a new class of T cell-based vaccines, has promoted Chip Clark from chief business officer to president and chief executive officer. Mr Clark joined Genocea in August 2010, having previously served as chief business officer at Vanda Pharmaceuticals, a biopharmaceutical company he co-founded in 2004.